These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2397740)

  • 1. Electrophysiological effects of dopamine autoreceptor antagonists, (+)-AJ 76 and (+)-UH 232.
    Piercey MF; Lum JT
    Eur J Pharmacol; 1990 Jul; 182(2):219-26. PubMed ID: 2397740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (+)-AJ 76 and (+)-UH 232: central stimulants acting as preferential dopamine autoreceptor antagonists.
    Svensson K; Johansson AM; Magnusson T; Carlsson A
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Nov; 334(3):234-45. PubMed ID: 2880302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo dopamine (DA) receptor binding and behavioural effects of the putative DA autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 in rats with a unilateral nigral 6-OH-DA lesion.
    Hajos M; Hjorth S; Svensson K; Carlsson A
    Exp Brain Res; 1988; 70(3):577-84. PubMed ID: 3133239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The putatively selective dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 stimulate prolactin release in rats.
    Svensson K; Carlsson M; Carlsson A; Hjorth S; Johansson AM; Eriksson E
    Eur J Pharmacol; 1986 Nov; 130(3):237-42. PubMed ID: 3792447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (+)-UH 232 and (+)-UH 242: novel stereoselective dopamine receptor antagonists with preferential action on autoreceptors.
    Svensson K; Hjorth S; Clark D; Carlsson A; Wikström H; Andersson B; Sanchez D; Johansson AM; Arvidsson LE; Hacksell U
    J Neural Transm; 1986; 65(1):1-27. PubMed ID: 3083041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine autoreceptor antagonists: effects on sleep-wake activity in the rat.
    Svensson K; Alföldi P; Hajós M; Rubicsek G; Johansson AM; Carlsson A; Obál F
    Pharmacol Biochem Behav; 1987 Jan; 26(1):123-9. PubMed ID: 3562484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the putative dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 on the discriminative stimulus properties of cocaine.
    Callahan PM; Piercey MF; Cunningham KA
    Psychopharmacology (Berl); 1992; 107(1):73-7. PubMed ID: 1589564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (1S,2R)-5-methoxy-1-methyl-2-(n-propylamino)tetralin ([+]-AJ-76) elevates transmitter synthesis in dopaminergic neurons surviving a partial nigrostriatal lesion.
    Hefti F
    Neuropharmacology; 1987 Aug; 26(8):1239-41. PubMed ID: 2889167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pharmacological analysis of the effects of (+)-AJ 76 and (+)-UH 232 at release regulating pre- and postsynaptic dopamine receptors.
    Gifford AN; Johnson KM
    Eur J Pharmacol; 1993 Jun; 237(2-3):169-75. PubMed ID: 8103459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic interactions between the NMDA antagonist dizocilpine and the preferential dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 with regard to locomotor stimulation in monoamine-depleted mice.
    Svensson A; Carlsson M; Carlsson A
    J Neural Transm Gen Sect; 1991; 85(1):69-77. PubMed ID: 1867840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of cocaine's pharmacological effects by the stimulant dopaminergic antagonists, (+)-AJ76 and (+)-UH232.
    Piercey MF; Lum JT; Hoffmann WE; Carlsson A; Ljung E; Svensson K
    Brain Res; 1992 Aug; 588(2):217-22. PubMed ID: 1393576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A homologous series of N-alkylated cis-(+)-(1 S, 2 R)-5-methoxy-1-methyl-2-aminotetralins: central dopamine receptor antagonists showing profiles ranging from classical antagonism to selectivity for autoreceptors.
    Svensson K; Carlsson A; Johansson AM; Arvidsson LE; Nilsson JL
    J Neural Transm; 1986; 65(1):29-38. PubMed ID: 3958706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yawning induced by the selective dopamine D2 agonist N-0437 is blocked by the selective dopamine autoreceptor antagonist (+)-UH 232.
    Cooper SJ; Rusk IN; Barber DJ
    Physiol Behav; 1989 Jun; 45(6):1263-6. PubMed ID: 2573095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing in rat brain slices through the substantia nigra pars compacta and ventral tegmental area.
    Bowery B; Rothwell LA; Seabrook GR
    Br J Pharmacol; 1994 Jul; 112(3):873-80. PubMed ID: 7921615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiological evaluation of a partial agonist of dopamine receptors.
    Piercey MF; Hoffmann WE; Vogelsang GD; Travis M
    J Pharmacol Exp Ther; 1987 Oct; 243(1):391-6. PubMed ID: 3668865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excitation of type II anterior caudate neurons by stimulation of dopamine D3 receptors.
    Piercey MF; Hyslop DK; Hoffmann WE
    Brain Res; 1997 Jul; 762(1-2):19-28. PubMed ID: 9262154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurophysiological evidence that D-1 dopamine receptor blockade attenuates postsynaptic but not autoreceptor-mediated effects of dopamine agonists.
    Carlson JH; Bergstrom DA; Walters JR
    Eur J Pharmacol; 1986 Apr; 123(2):237-51. PubMed ID: 2940101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dopamine D3 receptor and autoreceptor preferring antagonists (+)-AJ76 and (+)-UH232; a microdialysis study.
    Waters N; Lagerkvist S; Löfberg L; Piercey M; Carlsson A
    Eur J Pharmacol; 1993 Sep; 242(2):151-63. PubMed ID: 8253112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel dopamine receptor agonists and antagonists with preferential action on autoreceptors.
    Johansson AM; Arvidsson LE; Hacksell U; Nilsson JL; Svensson K; Hjorth S; Clark D; Carlsson A; Sanchez D; Andersson B
    J Med Chem; 1985 Aug; 28(8):1049-53. PubMed ID: 3927002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194.
    Audinot V; Newman-Tancredi A; Gobert A; Rivet JM; Brocco M; Lejeune F; Gluck L; Desposte I; Bervoets K; Dekeyne A; Millan MJ
    J Pharmacol Exp Ther; 1998 Oct; 287(1):187-97. PubMed ID: 9765337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.